Merck Aktie
137,00
EUR
+2,40
EUR
+1,78
%
Kursziele der Merck-Aktie in EUR
Das durchschnittliche Kursziel beinhaltet alle Analysen eines Analysten und nicht nur die jeweils aktuellste Analyse, die im Chart dargestellt wird.
Diese Analysten bewerten die Merck-Aktie
| Analyst | Kursziel | Abstand Kursziel | Datum | |
|---|---|---|---|---|
| UBS AG | 190,00 EUR | +38,48% | 27.02.2025 | |
| Goldman Sachs Group Inc. | 185,00 EUR | +34,84% | 19.02.2025 | |
| JP Morgan Chase & Co. | 190,00 EUR | +38,48% | 18.02.2025 | |
| Deutsche Bank AG | 174,00 EUR | +26,82% | 31.01.2025 | |
| Bernstein Research | 168,00 EUR | +22,45% | 07.01.2025 | |
| DZ BANK | - | - | 02.12.2024 | |
| Jefferies & Company Inc. | 180,00 EUR | +31,20% | 14.11.2024 | |
| Barclays Capital | 195,00 EUR | +42,13% | 01.08.2024 |
Werbung
Kursziele im Branchenvergleich
| Aktie | Buy | Hold | Sell | Ø Kursziel | Abst. Kursziel |
|---|---|---|---|---|---|
| 3M Co. | 0 | 0 | 0 | - | - |
| Abbott Laboratories | 0 | 0 | 0 | - | - |
| AstraZeneca PLC | 6 | 3 | 0 | 139,58 GBP | - |
| BASF | 6 | 5 | 0 | 55,00 EUR | +3,73% |
| Bayer | 1 | 8 | 0 | 24,12 EUR | -0,90% |
| BB Biotech AG | 0 | 0 | 0 | - | - |
| Beiersdorf AG | 8 | 1 | 2 | 146,00 EUR | +6,38% |
| Biotest AG Vz. | 0 | 0 | 0 | - | - |
| Bristol-Myers Squibb Co. | 0 | 0 | 0 | - | - |
| Clorox Co., The | 0 | 0 | 0 | - | - |
| Colgate-Palmolive Co. | 0 | 0 | 0 | - | - |
| Eli Lilly | 1 | 0 | 0 | 994,00 USD | +6,91% |
| Gilead Sciences Inc. | 0 | 0 | 0 | - | - |
| GSK PLC Registered Shs | 2 | 6 | 1 | 16,62 GBP | +12,07% |
| H. B. Fuller Co. | 0 | 0 | 0 | - | - |
| H&R GmbH & Co. KGaA | 0 | 1 | 0 | - | - |
| Johnson & Johnson | 0 | 0 | 0 | - | - |
| L'Oréal S.A. (L'Oreal, L Oreal) | 3 | 5 | 2 | 380,11 EUR | +4,71% |
| LANXESS AG | 4 | 3 | 3 | 28,56 EUR | -10,19% |
| Merck Co. | 0 | 0 | 0 | - | - |
| Merck KGaA | 7 | 1 | 0 | 183,14 EUR | +33,48% |
| Novartis AG | 3 | 5 | 1 | 99,12 CHF | -0,88% |
| Pfizer Inc. | 3 | 3 | 0 | 30,40 USD | +17,19% |
| Procter & Gamble Co. | 0 | 0 | 0 | - | - |
| Reckitt Benckiser Plc | 2 | 7 | 0 | 54,84 GBP | +5,75% |
| Roche Holding AG (Inhaberaktie) | 0 | 0 | 0 | - | - |
| Sanofi S.A. | 6 | 2 | 0 | 114,14 EUR | +5,20% |
| STADA | 0 | 0 | 0 | - | - |
| Takeda Pharmaceutical Co. Ltd. | 0 | 0 | 0 | - | - |
| Unilever plc | 6 | 1 | 3 | 48,67 GBP | +7,25% |
| WACKER CHEMIE AG | 6 | 2 | 0 | 100,17 EUR | +35,07% |